High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$15.0M
$14,973,832
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Other
|
2026-03-11 | $870,000 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-11 | $2,145,673Largex3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $334,272x4 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$417,521x4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $417,521x4 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $417,521x4 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $7,378,583Whalex2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $181,322x3 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$499,148x3
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $499,148x3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $673,710x3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2026-02-25 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $2,707,813Largex5 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Other
|
2026-02-20 | $122,750 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -76.0%
2026-02-20
$218,270x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -76.0%
|
2026-02-20 | $218,270x2 | S | Form 4 |